
Pfizer reported today final results of the phase 2/3 EPIC-HR trial, findings that confirm the investigational drug's 89% efficacy against severe COVID-19 disease.

Pfizer reported today final results of the phase 2/3 EPIC-HR trial, findings that confirm the investigational drug's 89% efficacy against severe COVID-19 disease.

New research presented at EuroEcho 2021 may help explain why some patients with long COVID-19 experience persistent dyspnea even 1 year after recovery.

COVID-19, in an attempt to bully Flu and potentially gain precious lung space in humans this year, provoked the veteran virus, labeling him as "irrelevant." Flu responds.
Influenza takes questions from key media outlets to rebut assertions by COVID-19 that Flu's heyday has come to an end. He replies to MSNBC, Fox News, CBS, & the Christian Science Monitor.

Excess adiposity and genetic predisposition both were found to be associated with a higher risk of gout, particularly among US women, in a new prospective study.

Referencing waning immunity of the 2-dose mRNA series and availability of the vaccine to youth in this age group for more than a year, FDA determined that benefits outweigh risks.

AHA Scientific Sessions 2021 recap, tests of clinical knowledge, expert interviews, and more in this roundup from Patient Care Online.

Increases in obesity parameters significantly increased risk of incident heart failure in persons with diabetes, but not without diabetes, in a large community-based cohort study.

Intranasal CGRP inhibitor zavegepant met coprimary regulatory endpoints in pivotal phase 3 trial in adults with migraine; FDA submission planned for Q1 2022.

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

New preliminary laboratory data showed 3 doses of the Pfizer-BioNTech COVID-19 vaccine neutralized the Omicron variant while 2 doses reduced neutralization titers.

The annual "America's Health Rankings" report found Louisiana ranked lowest in 3 of the 5 categories assessed. Find the 5 states ranking highest and lowest in each for 2021.

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

A digital text highlighter/scanner that translates and talks back; those stethoscopes with the wild-animal themed tubing. Check them out, plus 8 more Great Doctor Gifts.

Get a quick look at 12 of the many FDA-approved drugs in 2021 for conditions commonly seen in primary care.

The Guideline Toplines slide-show feature offers busy primary care physicians at-a-glance summaries of new and updated clinical guidelines across therapeutic areas.

Getting sick with COVID-19 is more worrisome to US adults than contracting the flu, the NFID found. How will that impact uptake of the flu shot this season?

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

A J&J booster shot following a 2-dose regimen of the Pfizer vaccine produced a greater CD8+ T-cell response than a third Pfizer dose, according to preliminary data.

Daily e-cigarette use was associated with more than twice the odds of reporting erectile dysfunction vs never using e-cigarettes, independent of other common ED risk factors.